Definitive Healthcare Corp Stock Analysis

DH Stock  USD 2.32  0.04  1.75%   
Below is the normalized historical share price chart for Definitive Healthcare Corp extending back to September 15, 2021. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Definitive Healthcare stands at 2.32, as last reported on the 30th of January, with the highest price reaching 2.33 and the lowest price hitting 2.21 during the day.
IPO Date
15th of September 2021
200 Day MA
3.2601
50 Day MA
2.5309
Beta
1.599
 
Covid
 
Interest Hikes
Definitive Healthcare holds a debt-to-equity ratio of 0.188. As of now, Definitive Healthcare's Interest Debt Per Share is decreasing as compared to previous years. The Definitive Healthcare's current Cash Flow To Debt Ratio is estimated to increase to 0.22, while Short and Long Term Debt is projected to decrease to under 9.6 M. With a high degree of financial leverage come high-interest payments, which usually reduce Definitive Healthcare's Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

Definitive Healthcare's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Definitive Healthcare's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Definitive Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Definitive Healthcare's stakeholders.
For most companies, including Definitive Healthcare, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Definitive Healthcare Corp, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Definitive Healthcare's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
0.8232
Enterprise Value Ebitda
46.6922
Price Sales
0.9795
Shares Float
36.8 M
Wall Street Target Price
3.9063
As of now, Definitive Healthcare's Total Stockholder Equity is decreasing as compared to previous years. The Definitive Healthcare's current Liabilities And Stockholders Equity is estimated to increase to about 1.4 B, while Common Stock Total Equity is projected to decrease to under 82.9 K. . The current Price To Sales Ratio is estimated to decrease to 2.08. The current Price Earnings Ratio is estimated to decrease to -1.1.
Definitive Healthcare Corp is overvalued with Real Value of 2.05 and Target Price of 3.91. The main objective of Definitive Healthcare stock analysis is to determine its intrinsic value, which is an estimate of what Definitive Healthcare Corp is worth, separate from its market price. There are two main types of Definitive Healthcare's stock analysis: fundamental analysis and technical analysis.
The Definitive Healthcare stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Definitive Healthcare's ongoing operational relationships across important fundamental and technical indicators.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Definitive Healthcare Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Definitive Stock Analysis Notes

About 94.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Definitive Healthcare has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 1.72. The firm had not issued any dividends in recent years. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Definitive Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 676 people. To learn more about Definitive Healthcare Corp call Kevin Coop at 508 720 4224 or check out https://www.definitivehc.com.

Definitive Healthcare Quarterly Total Revenue

60.05 Million

Definitive Healthcare Investment Alerts

Definitive Healthcare generated a negative expected return over the last 90 days
Definitive Healthcare has high historical volatility and very poor performance
Definitive Healthcare has a very high chance of going through financial distress in the upcoming years
The company generated the yearly revenue of 252.2 M. Annual Net Loss to common stockholders was (591.45 M) with gross profit of 203.3 M.
Over 94.0% of the company shares are held by institutions such as insurance companies
Latest headline from globenewswire.com: Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast

Definitive Largest EPS Surprises

Earnings surprises can significantly impact Definitive Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-26
2024-12-310.07180.080.008211 
2025-11-06
2025-09-300.060.070.0116 
2024-02-28
2023-12-310.080.07-0.0112 
View All Earnings Estimates

Definitive Healthcare Environmental, Social, and Governance (ESG) Scores

Definitive Healthcare's ESG score is a quantitative measure that evaluates Definitive Healthcare's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Definitive Healthcare's operations that may have significant financial implications and affect Definitive Healthcare's stock price as well as guide investors towards more socially responsible investments.

Definitive Healthcare Thematic Classifications

In addition to having Definitive Healthcare stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Health Management Idea
Health Management
Healthcare providers, hospitals

Definitive Stock Institutional Investors

Shares
Bank Of America Corp2025-06-30
769.4 K
New York State Common Retirement Fund2025-06-30
766.4 K
Renaissance Technologies Corp2025-06-30
703.4 K
Aqr Capital Management Llc2025-06-30
665 K
Ubs Group Ag2025-06-30
476.3 K
Charles Schwab Investment Management Inc2025-06-30
402.1 K
Connor Clark & Lunn Inv Mgmt Ltd2025-06-30
361 K
Northern Trust Corp2025-06-30
345.5 K
Citadel Advisors Llc2025-06-30
333.1 K
Advent International Lp2025-06-30
62.5 M
Goldman Sachs Group Inc2025-06-30
8.7 M
Note, although Definitive Healthcare's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Definitive Market Capitalization

The company currently falls under 'Small-Cap' category with a market capitalization of 237.32 M.

Definitive Profitablity

The company has Net Profit Margin (PM) of (0.78) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.06) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.06.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.19)(1.13)
Return On Capital Employed(0.88)(0.84)
Return On Assets(0.44)(0.41)
Return On Equity(1.07)(1.02)

Management Efficiency

The Definitive Healthcare's current Return On Tangible Assets is estimated to increase to -1.13. The Definitive Healthcare's current Return On Capital Employed is estimated to increase to -0.84. As of now, Definitive Healthcare's Intangibles To Total Assets are decreasing as compared to previous years. The Definitive Healthcare's current Fixed Asset Turnover is estimated to increase to 29.06, while Net Tangible Assets are projected to decrease to (682 M). Definitive Healthcare's management efficiency ratios could be used to measure how well Definitive Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 5.99  5.69 
Tangible Book Value Per Share(0.65)(0.68)
Enterprise Value Over EBITDA(1.27)(1.21)
Price Book Value Ratio 1.24  1.18 
Enterprise Value Multiple(1.27)(1.21)
Price Fair Value 1.24  1.18 
Enterprise Value721.2 M685.1 M
Examining the leadership quality of Definitive Healthcare Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Operating Margin
(0.06)
Profit Margin
(0.78)
Beta
1.599
Return On Assets
(0.01)
Return On Equity
(0.49)

Technical Drivers

As of the 30th of January, Definitive Healthcare shows the Variance of 15.74, standard deviation of 3.97, and Mean Deviation of 2.56. Definitive Healthcare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Definitive Healthcare Price Movement Analysis

Execute Study
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Definitive Healthcare middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Definitive Healthcare. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Definitive Healthcare Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Casey Heller over a week ago
Disposition of 1244 shares by Casey Heller of Definitive Healthcare at 3.74 subject to Rule 16b-3
 
Casey Heller over three weeks ago
Acquisition by Casey Heller of 195313 shares of Definitive Healthcare subject to Rule 16b-3
 
Benjamin Graboske over a month ago
Disposition of 341417 shares by Benjamin Graboske of Definitive Healthcare at 2.53 subject to Rule 16b-3
 
Shamsuddin Kate Marie over three months ago
Acquisition by Shamsuddin Kate Marie of 33933 shares of Definitive Healthcare subject to Rule 16b-3
 
Richard Booth over three months ago
Disposition of 10192 shares by Richard Booth of Definitive Healthcare at 4.41 subject to Rule 16b-3
 
Richard Booth over three months ago
Disposition of 7873 shares by Richard Booth of Definitive Healthcare at 2.75 subject to Rule 16b-3
 
Jason Krantz over three months ago
Disposition of 4093 shares by Jason Krantz of Definitive Healthcare at 4.15 subject to Rule 16b-3
 
Jason Krantz over six months ago
Disposition of 18796 shares by Jason Krantz of Definitive Healthcare at 3.74 subject to Rule 16b-3
 
Richard Booth over six months ago
Disposition of 27080 shares by Richard Booth of Definitive Healthcare at 4.86 subject to Rule 16b-3
 
Shamsuddin Kate Marie over six months ago
Disposition of 1012 shares by Shamsuddin Kate Marie of Definitive Healthcare at 3.65 subject to Rule 16b-3
 
Paris Jonathan over six months ago
Insider Trading
 
Jason Krantz over six months ago
Disposition of 22615 shares by Jason Krantz of Definitive Healthcare at 4.41 subject to Rule 16b-3

Definitive Healthcare Predictive Daily Indicators

Definitive Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Definitive Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Definitive Healthcare Forecast Models

Definitive Healthcare's time-series forecasting models are one of many Definitive Healthcare's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Definitive Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Definitive Healthcare Debt to Cash Allocation

As Definitive Healthcare Corp follows its natural business cycle, the capital allocation decisions will not magically go away. Definitive Healthcare's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Definitive Healthcare Corp reports 253.11 M of total liabilities with total debt to equity ratio (D/E) of 0.19, which may suggest the company is not taking enough advantage from financial leverage. Definitive Healthcare has a current ratio of 3.25, indicating that it is in good position to pay out its debt commitments in time. That said, strategic use of leverage may enable Definitive to fund expansion initiatives and generate superior returns.

Definitive Healthcare Total Assets Over Time

Definitive Healthcare Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Definitive Healthcare uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Definitive Healthcare Debt Ratio

    
  21.0   
It feels like most of the Definitive Healthcare's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Definitive Healthcare's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Definitive Healthcare, which in turn will lower the firm's financial flexibility.

Definitive Short Long Term Debt Total

Short Long Term Debt Total

262.51 Million

As of now, Definitive Healthcare's Short and Long Term Debt Total is decreasing as compared to previous years.

About Definitive Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Definitive Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Definitive shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Definitive Healthcare. By using and applying Definitive Stock analysis, traders can create a robust methodology for identifying Definitive entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(2.89)(2.75)
Operating Profit Margin(3.24)(3.08)
Net Loss(1.88)(1.79)
Gross Profit Margin 0.70  0.58 

Current Definitive Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Definitive analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Definitive analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
3.91Buy14Odds
Definitive Healthcare Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Definitive analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Definitive stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Definitive Healthcare, talking to its executives and customers, or listening to Definitive conference calls.
Definitive Analyst Advice Details

Definitive Stock Analysis Indicators

Definitive Healthcare Corp stock analysis indicators help investors evaluate how Definitive Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Definitive Healthcare shares will generate the highest return on investment. By understating and applying Definitive Healthcare stock analysis, traders can identify Definitive Healthcare position entry and exit signals to maximize returns.
Begin Period Cash Flow131 M
Total Stockholder Equity444.4 M
Capital Lease Obligations10 M
Property Plant And Equipment Net11.3 M
Cash And Short Term Investments290.2 M
Cash105.4 M
50 Day M A2.5309
Net Interest Income-245 K
Total Current Liabilities161.2 M
Forward Price Earnings8.4104
Investments-26.4 M
Interest Expense14.8 M
Stock Based Compensation38.1 M
Long Term Debt229.4 M
Common Stock Shares Outstanding116.6 M
Total Cashflows From Investing Activities-26.4 M
Tax Provision-42.3 M
Accounts Payable10.8 M
Net Debt147.7 M
Other Operating Expenses963 M
Non Current Assets Total719.2 M
Liabilities And Stockholders Equity1.1 B
Non Currrent Assets Other16.7 M

Complementary Tools for Definitive Stock analysis

When running Definitive Healthcare's price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm